Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jun;67(6):1372–1380. doi: 10.1038/bjc.1993.254

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.

F V Cromme 1, C J Meijer 1, P J Snijders 1, A Uyterlinde 1, P Kenemans 1, T Helmerhorst 1, P L Stern 1, A J van den Brule 1, J M Walboomers 1
PMCID: PMC1968477  PMID: 8390286

Abstract

Cervical intraepithelial neoplasia (CIN) grades I to III lesions (n = 94) and squamous cell carcinomas of the uterine cervix (n = 27) were analysed for MHC class I and II expression and presence of HPV genotypes. MHC class I and II expression was studied by immunohistochemistry and HPV typing was performed by general primer- and type-specific primer mediated PCR (GP/TS PCR). Both techniques were performed on paraffin embedded tissue sections. Results show disturbed MHC class I heavy chain expression in CIN I to CIN III, as well as in cervical carcinomas. Upregulated MHC class II expression on dysplastic epithelial cells was also found in the different CIN groups and carcinomas. Prevalence of HPV genotypes increased with the severity of the lesion, mainly due to the contribution of the HPV types 16 and 18. No correlation could be established between the presence of specific HPV genotypes and any MHC expression pattern in the different CIN groups or cervical carcinomas. In some cases these data were confirmed by RNA in situ hybridisation showing HPV 16 E7 transcripts in the same dysplastic/neoplastic cells from which MHC status was determined. The results indicate that local differences may exist in the type of cellular immune response to HPV induced lesions.

Full text

PDF
1372

Images in this article

1375Figure 1
on p.1375
1376Figure 2
on p.1376
1378Figure 4
on p.1378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson M. L., Stam N. J., Klein G., Ploegh H. L., Masucci M. G. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. Int J Cancer. 1991 Feb 20;47(4):544–550. doi: 10.1002/ijc.2910470412. [DOI] [PubMed] [Google Scholar]
  2. Bröcker E. B., Suter L., Brüggen J., Ruiter D. J., Macher E., Sorg C. Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer. 1985 Jul 15;36(1):29–35. doi: 10.1002/ijc.2910360106. [DOI] [PubMed] [Google Scholar]
  3. Connor M. E., Stern P. L. Loss of MHC class-I expression in cervical carcinomas. Int J Cancer. 1990 Dec 15;46(6):1029–1034. doi: 10.1002/ijc.2910460614. [DOI] [PubMed] [Google Scholar]
  4. Doyle A., Martin W. J., Funa K., Gazdar A., Carney D., Martin S. E., Linnoila I., Cuttitta F., Mulshine J., Bunn P. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med. 1985 May 1;161(5):1135–1151. doi: 10.1084/jem.161.5.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dürst M., Dzarlieva-Petrusevska R. T., Boukamp P., Fusenig N. E., Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1987;1(3):251–256. [PubMed] [Google Scholar]
  6. Esteban F., Ruiz-Cabello F., Concha A., Pérez-Ayala M., Sánchez-Rozas J. A., Garrido F. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis. 1990 Jul-Aug;8(4):319–328. doi: 10.1007/BF01810678. [DOI] [PubMed] [Google Scholar]
  7. Ferguson A., Moore M., Fox H. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes. Br J Cancer. 1985 Oct;52(4):551–563. doi: 10.1038/bjc.1985.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fleming K. A., McMichael A., Morton J. A., Woods J., McGee J. O. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol. 1981 Jul;34(7):779–784. doi: 10.1136/jcp.34.7.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Glew S. S., Duggan-Keen M., Cabrera T., Stern P. L. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res. 1992 Jul 15;52(14):4009–4016. [PubMed] [Google Scholar]
  10. Gutierrez J., López-Nevot M. A., Cabrera T., Oliva R., Esquivias J., Ruiz-Cabello F., Garrido F. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness. Exp Clin Immunogenet. 1987;4(3):144–152. [PubMed] [Google Scholar]
  11. Lungu O., Sun X. W., Felix J., Richart R. M., Silverstein S., Wright T. C., Jr Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA. 1992 May 13;267(18):2493–2496. [PubMed] [Google Scholar]
  12. McCance D. J., Kopan R., Fuchs E., Laimins L. A. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7169–7173. doi: 10.1073/pnas.85.19.7169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McDougall C. J., Ngoi S. S., Goldman I. S., Godwin T., Felix J., DeCosse J. J., Rigas B. Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res. 1990 Dec 15;50(24):8023–8027. [PubMed] [Google Scholar]
  14. Ostrand-Rosenberg S., Roby C., Clements V. K., Cole G. A. Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes. Int J Cancer Suppl. 1991;6:61–68. doi: 10.1002/ijc.2910470714. [DOI] [PubMed] [Google Scholar]
  15. Oudejans C. B., Krimpenfort P., Ploegh H. L., Meijer C. J. Lack of expression of HLA-B27 gene in transgenic mouse trophoblast. Conserved genetic pressures underlying extra-embryonic development. J Exp Med. 1989 Feb 1;169(2):447–456. doi: 10.1084/jem.169.2.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pirisi L., Yasumoto S., Feller M., Doniger J., DiPaolo J. A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol. 1987 Apr;61(4):1061–1066. doi: 10.1128/jvi.61.4.1061-1066.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richart R. M. Causes and management of cervical intraepithelial neoplasia. Cancer. 1987 Oct 15;60(8 Suppl):1951–1959. doi: 10.1002/1097-0142(19901015)60:8+<1951::aid-cncr2820601505>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  18. Ruiter D. J., Bröcker E. B., Ferrone S. Expression and susceptibility to modulation by interferons of HLA class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance. J Immunogenet. 1986 Apr-Jun;13(2-3):229–234. doi: 10.1111/j.1744-313x.1986.tb01105.x. [DOI] [PubMed] [Google Scholar]
  19. Ruiz-Cabello F., Klein E., Garrido F. MHC antigens on human tumors. Immunol Lett. 1991 Aug;29(3):181–189. doi: 10.1016/0165-2478(91)90168-a. [DOI] [PubMed] [Google Scholar]
  20. Schrier P. I., Bernards R., Vaessen R. T., Houweling A., van der Eb A. J. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. 1983 Oct 27-Nov 2Nature. 305(5937):771–775. doi: 10.1038/305771a0. [DOI] [PubMed] [Google Scholar]
  21. Signäs C., Katze M. G., Persson H., Philipson L. An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature. 1982 Sep 9;299(5879):175–178. doi: 10.1038/299175a0. [DOI] [PubMed] [Google Scholar]
  22. Snijders P. J., van den Brule A. J., Schrijnemakers H. F., Snow G., Meijer C. J., Walboomers J. M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990 Jan;71(Pt 1):173–181. doi: 10.1099/0022-1317-71-1-173. [DOI] [PubMed] [Google Scholar]
  23. Stam N. J., Spits H., Ploegh H. L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol. 1986 Oct 1;137(7):2299–2306. [PubMed] [Google Scholar]
  24. Stam N. J., Vroom T. M., Peters P. J., Pastoors E. B., Ploegh H. L. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol. 1990;2(2):113–125. doi: 10.1093/intimm/2.2.113. [DOI] [PubMed] [Google Scholar]
  25. Van Den Brule A. J., Walboomers J. M., Du Maine M., Kenemans P., Meijer C. J. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer. 1991 May 30;48(3):404–408. doi: 10.1002/ijc.2910480317. [DOI] [PubMed] [Google Scholar]
  26. Walboomers J. M., Melchers W. J., Mullink H., Meijer C. J., Struyk A., Quint W. G., van der Noordaa J., ter Schegget J. Sensitivity of in situ detection with biotinylated probes of human papilloma virus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol. 1988 Jun;131(3):587–594. [PMC free article] [PubMed] [Google Scholar]
  27. Warhol M. J., Gee B. The expression of histocompatibility antigen HLA-DR in cervical squamous epithelium infected with human papilloma virus. Mod Pathol. 1989 Mar;2(2):101–104. [PubMed] [Google Scholar]
  28. Woodworth C. D., Waggoner S., Barnes W., Stoler M. H., DiPaolo J. A. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res. 1990 Jun 15;50(12):3709–3715. [PubMed] [Google Scholar]
  29. van den Brule A. J., Cromme F. V., Snijders P. J., Smit L., Oudejans C. B., Baak J. P., Meijer C. J., Walboomers J. M. Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy. Am J Pathol. 1991 Nov;139(5):1037–1045. [PMC free article] [PubMed] [Google Scholar]
  30. van den Brule A. J., Meijer C. J., Bakels V., Kenemans P., Walboomers J. M. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol. 1990 Dec;28(12):2739–2743. doi: 10.1128/jcm.28.12.2739-2743.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. zur Hausen H. Papillomavirus in anogenital cancer: the dilemma of epidemiologic approaches. J Natl Cancer Inst. 1989 Nov 15;81(22):1680–1682. doi: 10.1093/jnci/81.22.1680. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES